Stay updated on Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial
Sign up to get notified when there's something new on the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page.

Latest updates to the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedA full list of trial locations across US states and Canadian provinces was added and the revision updated to v3.3.3, while prior location blocks and the HHS Vulnerability Disclosure entry were removed.SummaryDifference2%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe page footer updated from Revision: v3.3.1 to Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check46 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not be related to the study, and Revision: v3.3.1.SummaryDifference0.1%

- Check53 days agoChange DetectedThe banner warning about a lapse in government funding and potential delays in updates was removed from the page.SummaryDifference0.2%

- Check68 days agoChange DetectedNo significant changes were detected; the study details page content, sections, and links appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check96 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference1%

Stay in the know with updates to Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page.